- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
Christopher Yook (Chris)
News 13 results
In the News · Source: Law360
October 31, 2019
Tom Friel, Jim Brogan, Brian Eutermoser, Angela Tarasi, Mikaela Stone, Bobby Burchfield, Norman Armstrong and Chris Yook advise BASF
In the News · Source: Law360 and Bloomberg Law
In the News · Source: The Hollywood Reporter and Law360
April 30, 2019
Kenny Steinthal, Blake Cunningham, Christopher Yook and David Mattern represent Peloton in its antitrust dispute
In the News · Source: Reorg
In the News · Source: Reorg
March 8, 2019
Chris Yook discusses NxStage/Fresenius and why the FTC will continue to examine vertical transactions more closely
In the News · Source: Reorg
February 21, 2019
NxStage ‘Close Call’ Indicates FTC Will Continue to Examine Vertical Issues Closely
In the News · Source: Law360
In the News · Source: Law360
In the News · Source: Reorg
January 4, 2019
Chris Yook comments on the FTC's review of the NxStage/Fresenius deal likely focusing on IP licensing related to the Medisystems divestiture
Cases & Deals
January 29, 2018
King & Spalding Advises WestRock on Antitrust Aspects of $4.9 Billion Acquisition of KapStone
Cases & Deals
January 23, 2018
King & Spalding Advises Northlane Capital Partners on its Sale of SMG Holdings
Cases & Deals
December 20, 2017
LCCG Turns to King & Spalding on €230 Million Acquisition of GPE